Furthermore, tauopathies such as AD, FTD, CBD and PSP are characterised by different tau aggregation profiles and exhibit distinct pathological signatures.[20] The correlation between specific tau aggregate species and the clinical manifestations of these diseases remains unclear, but understanding this relationship is crucial for developing targeted therapeutics. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.